Tech Consultant Achieves Biomedical Breakthrough on a Budget
A Sydney-based tech consultant, Paul Conyngham, solved a critical biomedical challenge for just $3,000 and two months, significantly undercutting the billions spent by companies like Moderna. This breakthrough centers on a new approach to treating mast cell cancer in dogs, showcasing innovation outside traditional pharmaceutical routes.
A tech consultant in Sydney spent $3,000 and two months to do what Moderna has spent billions trying to scale.
Paul Conyngham adopted Rosie, a staffy-Shar Pei cross, from a shelter in 2019. In 2024, tumors started growing on her back leg. Mast cell cancer, the most common skin https://t.co/bi90mXiZPz https://t.co/3NezccNjd5